FDA Warns About Treating COVID-19 With Unproven Drugs
Chloroquine, hydroxychloroquine may trigger potentially fatal heart rhythm problems in COVID-19 patients
HTN, Obesity, Diabetes Common in U.S. COVID-19 Patients
Twenty-one percent of hospitalized patients died; 88.1 percent requiring mechanical ventilation died
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Mild, No Symptoms for Most Children With SARS-CoV-2 Infection
Main radiologic findings are bronchial thickening, ground-glass opacities; also seen when asymptomatic
ACEIs/ARBs Not Linked to Severity or Mortality of COVID-19
Percentage of patients with hypertension taking ACEIs/ARBs similar for survivors, nonsurvivors
White House Announces Payment Plan for Uninsured COVID-19 Patients
Doctors can submit bills for these patients directly to the government and be paid at Medicare rates
CDC: More Chemical Exposures Reported in January to March 2020
Increases of 20.4 and 16.4 percent from January to March 2019 and January to March 2018
Chronic Conditions, Obesity Common in Fatal Cases of EVALI
More fatal and nonfatal cases were male and non-Hispanic white versus other race, ethnic groups
Lopinavir/Ritonavir, Umifenovir Ineffective for Mild COVID-19
Rate of positive-to-negative conversion of SARS-CoV-2 did not differ for drug therapy versus standard care
AAD Establishes Registry for Skin Manifestations of COVID-19
Initial study describes cutaneous involvement, which was reported in 20.4 percent of 88 patients
